β-blockers in hypertension: Is carvedilol different?

Franz H. Messerli, Ehud Grossman

Research output: Contribution to journalArticlepeer-review

Abstract

Most studies assessing the effects of β-blockers were carried out with traditional, β1-selective β-blockers, such as metoprolol and atenolol. Pathophysiologic and pharmacologic studies have documented that not all β-blockers are created equal. In particular, the pharmacologic and clinical profiles of the newer, vasodilating β-blockers, such as carvedilol, have been shown to differ from those of the traditional β-blockers. These differences, although relevant in the younger patient with hypertension, are particularly important in elderly patients in whom traditional β-blockers may not be as effective or as well tolerated as the newer vasodilating agents.

Original languageEnglish
Pages (from-to)7-12
Number of pages6
JournalAmerican Journal of Cardiology
Volume93
Issue number9 SUPPL. 1
DOIs
StatePublished - 6 May 2004

Fingerprint

Dive into the research topics of 'β-blockers in hypertension: Is carvedilol different?'. Together they form a unique fingerprint.

Cite this